U.S. Sen. Rob Portman (R-OH) praised the U.S. Department of Health and Human Services' decision to lift requirements on physicians to prescribe drugs to help patients struggling with addiction medicat...
Read More
A team of scientists, led by Duke University, have developed a bio-compatible surgical patch that releases nonopioid painkillers directly to the site of a wound. The polymer patch, made of poly(est...
Read More
A new study suggests that collaboration between physicians and pharmacists may increase the adherence to and participant satisfaction of treatments for opioid use disorder. Researchers at Duke Uni...
Read More
Counsel for the American Hospital Association (AHA) and other groups have put drug companies on notice that they need to immediately halt their practice of eliminating drug discounts for contract phar...
Read More
The U.S. Food and Drug Administration (FDA) said it will be taking steps to clarify new drug development in the age of individualized medicine. Given advances in scientific knowledge and drug deve...
Read More
The American Society of Addiction Medicine recommended that the Drug Enforcement Administration change its rules on implantable and injectable buprenorphine as part of its comments on the SUPPORT Act ...
Read More
The U.S. Department of Health and Human Services Office of General Counsel released an advisory opinion on Wednesday clarifying discounts from drug manufacturers under the 340B Drug Pricing Program re...
Read More
The New Lenox Safe Communities America Coalition, in partnership with the Will County Executive’s Office, will offer Narcan training on Jan. 25. The free training will be held via Zoom. The eve...
Read More
U.S. Rep. Fred Keller (R-PA) stressed the importance of holding companies like Purdue Pharma, and the Sackler family that owns it, accountable for their part in the opioid epidemic. While particip...
Read More
Manitoba recently changed the classification of naloxone, an opioid overdose antidote, from a Schedule II drug to an unscheduled drug. The move is expected to reduce opioid overdose deaths and remove...
Read More
U.S. Sens. Chuck Grassley (R-IA), chair of the Senate Finance Committee, and Ron Wyden (D-OR), the finance committee’s ranking member, presented a report to the committee Wednesday illuminating the ...
Read More
The U.S. Department of Justice recently awarded the Wisconsin Department of Safety and Professional Services (DSPS) a $1.9 million grant for its Wisconsin Enhanced Prescription Drug Monitoring Program...
Read More
The U.S. Veterans Health Administration (VHA) will host a webinar for community providers on Dec. 17 to discuss opioid use disorder (OUD) among Veteran patients. The webinar, Opioid Use Disorder Tr...
Read More
U.S. Rep. Steve Stivers (R-OH) applauded the U.S. Drug Enforcement Administration’s proposed rule on partial fill prescriptions. The DEA’s ruling plays an important role in implementing Stiver...
Read More
The Department of Drug and Alcohol Programs (DDAP), in partnership with the Liberty Mid-Atlantic High Intensity Trafficking Area (LMA HIDTA) Program, recently held a virtual, two-day Psychostimulant S...
Read More
Patients at risk for opioid misuse were prescribed opioids for noncancer pain at a similar rate to those not at risk, Saint Louis University researchers found. The Centers for Disease Control (CDC)...
Read More
On Tuesday, U.S. Sen. Josh Hawley (R-MO) blasted consulting firm McKinsey & Company for its proposal to provide pharmacies with bounties on opioid overdoses. In a letter to McKinsey managing partn...
Read More
The American Society of Addiction Medicine asked Congress Friday to oppose the Marijuana Opportunity Reinvestment and Expungement (MORE) Act of 2019. In a letter to congressional leaders, ASAM sai...
Read More
Pennsylvania Gov. Tom Wolf recently signed into law Act 117 of 2020 that adds carfentanil to the list of Schedule II controlled substances. Addition to the list means the drug is illegal to posses...
Read More
U.S. Sens. Elizabeth Warren (D-MA) and Tammy Baldwin (D-WI) want the General Accounting Office (GAO) to investigate mandatory work requirements at drug and alcohol treatment facilities that receive fe...
Read More